A p53-derived peptide studied for its ability to selectively target and induce apoptosis (cell death) in malignant cancer cells without harming healthy tissue.
PNC-28 is a synthetic peptide derived from a segment of the p53 tumor suppressor protein. It has been studied in preclinical models for its potential ability to interact with HDM-2 (human double minute 2) pathways and induce apoptosis (programmed cell death) in certain malignant cells. In laboratory research, PNC-28 has demonstrated selective cytotoxic effects toward cancerous cells while sparing normal, healthy tissue. It remains an investigational compound and is not approved for the treatment of cancer or any disease.
PNC-28 is an investigational compound primarily discussed within research and academic settings.
